Testing effectiveness (Phase 2)Ended earlyNCT00581997
What this trial is testing
QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic Sclerosis
Who this might be right for
Pulmonary Fibrosis Secondary to Systemic Sclerosis
Novartis Pharmaceuticals 8